The reasons for this are complicated, but one thing is clear: Women may struggle to get diagnoses for health problems - including sleep apnea, thyroid issues and certain heart conditions ... a ...
Vanderbilt University has described muscarinic M4 receptor positive allosteric modulators (PAMs) reported to be useful for the treatment of Alzheimer’s disease, pain, schizophrenia, sleep disorders ...
Sosei Group (JP:4565) has released an update. Nxera Pharma has received a $3.5 million milestone payment from Centessa Pharmaceuticals following the initiation of a Phase 2 trial for ORX750, a ...
“Our research encourages further basic and clinical research on CBN as a new treatment strategy for sleep disorders, including insomnia. Our clinical study only administered CBN on a single occasion.